Free Trial

Research Analysts Issue Forecasts for Hawkins Q3 Earnings

Hawkins logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Sidoti lowered Hawkins’ Q3 2027 EPS forecast to $0.71 from $0.76, while projecting $4.15 in FY2027 earnings. The current full-year consensus estimate is $4.19 per share.
  • Analyst sentiment remains cautious, with Hawkins carrying a consensus “Hold” rating and an average price target of $178.50. Barclays rated the stock equal weight at $157, while BWS Financial maintained a $200 buy target.
  • Hawkins recently exceeded quarterly expectations, reporting $1.34 EPS versus the $1.19 consensus and revenue of $313.82 million. The company also raised its quarterly dividend to $0.20 per share, or $0.80 annually.
  • Interested in Hawkins? Here are five stocks we like better.

Hawkins, Inc. (NASDAQ:HWKN - Free Report) - Sidoti decreased their Q3 2027 EPS estimates for shares of Hawkins in a report issued on Friday, October 30th. Sidoti analyst D. Harriman now expects that the specialty chemicals company will post earnings of $0.71 per share for the quarter, down from their prior estimate of $0.76. The consensus estimate for Hawkins' current full-year earnings is $4.19 per share. Sidoti also issued estimates for Hawkins' Q4 2027 earnings at $0.75 EPS, FY2027 earnings at $4.15 EPS, Q1 2028 earnings at $1.54 EPS, Q2 2028 earnings at $1.52 EPS, Q3 2028 earnings at $0.90 EPS and Q4 2028 earnings at $1.04 EPS.

Several other analysts have also recently commented on HWKN. Barclays set a $157.00 target price on Hawkins and gave the stock an "equal weight" rating in a report on Thursday. Weiss Ratings upgraded Hawkins from a "hold (c)" rating to a "hold (c+)" rating in a research report on Monday, September 21st. BWS Financial restated a "buy" rating and set a $200.00 target price on shares of Hawkins in a research note on Tuesday, October 27th. Finally, Zacks Research raised Hawkins from a "strong sell" rating to a "hold" rating in a research report on Wednesday, October 28th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Hawkins has a consensus rating of "Hold" and an average price target of $178.50.

Read Our Latest Report on HWKN

Hawkins Price Performance

HWKN opened at $152.53 on Monday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.46 and a current ratio of 2.28. The company has a market cap of $3.17 billion, a PE ratio of 37.02, a price-to-earnings-growth ratio of 3.04 and a beta of 0.72. Hawkins has a 1 year low of $116.04 and a 1 year high of $174.12. The firm has a 50 day moving average price of $128.73 and a 200 day moving average price of $143.12.

Hawkins (NASDAQ:HWKN - Get Free Report) last announced its quarterly earnings results on Monday, October 26th. The specialty chemicals company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.15. The firm had revenue of $313.82 million during the quarter, compared to analysts' expectations of $302.70 million. Hawkins had a net margin of 7.53% and a return on equity of 15.97%.

Hawkins Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 25th. Shareholders of record on Wednesday, November 11th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 0.5%. This is a boost from Hawkins's previous quarterly dividend of $0.19. The ex-dividend date is Tuesday, November 10th. Hawkins's dividend payout ratio (DPR) is 19.42%.

Insider Transactions at Hawkins

In related news, CFO Jeffrey P. Oldenkamp bought 1,290 shares of the business's stock in a transaction on Thursday, August 27th. The stock was acquired at an average price of $119.00 per share, with a total value of $153,510.00. Following the transaction, the chief financial officer owned 104,223 shares in the company, valued at approximately $12,402,537. This trade represents a 1.25% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Douglas A. Lange purchased 910 shares of Hawkins stock in a transaction dated Tuesday, August 25th. The stock was acquired at an average price of $118.75 per share, with a total value of $108,062.50. Following the acquisition, the vice president owned 28,169 shares in the company, valued at approximately $3,345,068.75. This represents a 3.34% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 3.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in HWKN. BlackRock Inc. acquired a new stake in shares of Hawkins in the second quarter valued at $449,055,000. Giverny Capital Inc. bought a new stake in shares of Hawkins in the 2nd quarter valued at $13,493,000. Bank of America Corp DE purchased a new stake in shares of Hawkins during the 2nd quarter valued at approximately $12,860,000. Corient Private Wealth LP lifted its holdings in Hawkins by 79.5% in the second quarter. Corient Private Wealth LP now owns 8,842 shares of the specialty chemicals company's stock worth $1,256,000 after buying an additional 3,917 shares during the period. Finally, Public Employees Retirement System of Ohio purchased a new stake in Hawkins in the 2nd quarter worth $1,601,000. Institutional investors and hedge funds own 69.71% of the company's stock.

Hawkins Company Profile

(Get Free Report)

Hawkins, Inc NASDAQ: HWKN is a chemical manufacturer, blender and distributor serving customers across the United States. The company supplies a range of water treatment chemicals, industrial chemicals and specialty products to municipal, commercial and industrial users.

Its water treatment business provides chemicals and related solutions used in drinking water, wastewater and industrial water treatment applications. Hawkins also serves the industrial, health and nutrition, and specialty chemical markets, offering products such as chemical blends, custom formulations and other materials used in manufacturing, agriculture, food processing and pharmaceutical applications.

Founded in 1938, Hawkins is headquartered in Roseville, Minnesota, and operates through a network of manufacturing, blending, distribution and sales locations in the United States.

Further Reading

Earnings History and Estimates for Hawkins (NASDAQ:HWKN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hawkins Right Now?

Before you consider Hawkins, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.

While Hawkins currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines